Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors engaged.

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

The illicit trade of fake medicines is a “growing threat” in Europe, EU’s law enforcement agency warned today. There is a rise in the trade of either sub-standard, falsely labelled or falsified ...